iXensor receives Rohto Pharmaceutical’s investment to boost technology licensing
April 28th, 2022 | 🕒
iSpeech.org Taiwanese mobile health developer iXensor has obtained an undisclosed strategic investment from Rohto Pharmaceutical Co. to broaden the access
Gloss